Making Evidence-based Decisions Using Alzheimer Therapy (MEDUSA Therapy)

Not Applicable

Completed

• Conditions: Alzheimer's disease; Nervous System Diseases

• Registration Number: ISRCTN55568578
• Lead Sponsor: Department of Health

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2004-09-30
• Last Update Posted: 17 October 2016

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 75

Inclusion Criteria

75 participants (i.e. 15 in each arm of the trial) with diagnosis of Alzheimer's disease (AD) and aged between 55 and 95

Exclusion Criteria

Does not match inclusion criteria

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Clinical Global Impression of Change (CGI/C)<br>2. Mini-Mental State Examination (MMSE)<br>3. BAYER-Activities of Daily Living (ADL)<br>4. Neuropsychiatric inventory questionnaire (NPI-Q)<br>5. Global Assessment Scale (GAS)

Secondary Outcome Measures

Name	Time	Method
ot provided at time of registration